Antidiabetic Drugs and the Kidney

Current pharmaceutical design

Volumn 23, Issue 41, 2017, Pages 6310-6320

  Tsimihodimos, Vasilis ^a   Karanatsis, Nikolaos ^a   Tzavela, Eleftheria ^a   Elisaf, Moses ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

GLP 1 analogs; Kidney; pharmacokinetics; pioglitazone.; renal failure; renoprotection; SGLT2 inhibitors

Indexed keywords

ANTIDIABETIC AGENT;

DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY;

BLOOD GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY; KIDNEY DISEASES;

EID: 85052995047     PISSN: None     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612823666170307103222     Document Type: Review

References (0)